Search results with tag "Of multidrug"
Long-Term Care Regulatory Provider Letter
www.hhs.texas.govDec 21, 2021 · 2.3 Monitoring of Multidrug-Resistant Organisms NFs must include in their infection prevention and control programs a system of surveillance designed to identify possible multidrug-resistant organisms4. “Multidrug-resistant organisms” (MDROs) refer to 1 26 TAC §554.1207(c)(4) 2 26 TAC §554.1207(c)(5)(B) 3 26 TAC §554.1601(b)(4)
2022 NHSN Patient Safety Component Manual
www.cdc.govknown to prevent HAIs, the incidence or prevalence of multidrug -resistant organisms within their organizations, trends and coverage of healthcare personnel safety and vaccination, and adverse events related to the transfusion of blood and blood products.
Management of Multidrug-Resistant Organisms In …
www.cdc.govFeb 15, 2017 · Multidrug-resistant organisms (MDROs), including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE) and certain gram-negative bacilli (GNB) have important infection control implications that either have not been addressed or received only limited consideration in previous isolation guidelines.
Appendix A: Disease-Specific Chapters
www.health.gov.on.caThe incidence of multidrug-resistant TB (MDR-TB) in the province has fluctuated from 6 to 11 laboratory-confirmed cases per year. Extensively drug-resistant TB (XDR-TB) is very